Position Statement: Pert Shortage

Pancreatic enzyme replacement therapy (PERT) shortage – advice for the management of adults with pancreatic exocrine insufficiency

Position Statement: Pancreatic enzyme replacement therapy (PERT) shortage – advice for clinicians on the management of adults with pancreatic exocrine insufficiency
Phillips M.E1,3, McGeeney L.M1, Watson K-L2, Lowdon J2.
Position statement and advice for prescribers from the 1Nutrition Interest Group of the Pancreatic Society of Great Britain and Ireland (NIGPS), 2 Cystic Fibrosis Specialist Group and 3 Gastroenterology Specialist Group, British Dietetic Association.
Endorsed by the British Society of Gastroenterology (Pancreas section); Pancreatic Society of Great Britain and Ireland, Pancreatic Cancer UK, GUTS UK, Cystic Fibrosis Trust, CF Medical Association, Pancreatic Cancer Action, Neuroendocrine Cancer UK and the British Dietetic Association.
Issue date: 24th June 2024 (Version 3)
 

Position statement Clinicians	Position statement patients